| Primary |
| Skin Lesion |
57.1% |
| Arthritis Infective |
14.3% |
| Erysipelas |
14.3% |
| Staphylococcal Infection |
14.3% |
|
| Hypokalaemia |
40.0% |
| Skin Ulcer |
20.0% |
| Toxic Skin Eruption |
20.0% |
| White Blood Cell Count Increased |
20.0% |
|
| Secondary |
| Product Used For Unknown Indication |
33.3% |
| Diabetic Foot |
8.9% |
| Lower Respiratory Tract Infection |
7.7% |
| Hiv Infection |
6.5% |
| Anaesthesia |
4.8% |
| Drug Use For Unknown Indication |
4.8% |
| Hypertension |
4.8% |
| Postoperative Wound Infection |
4.8% |
| Staphylococcal Infection |
3.6% |
| Atrial Fibrillation |
2.4% |
| Infection |
2.4% |
| Renal Transplant |
2.4% |
| Skin Infection |
2.4% |
| Angina Pectoris |
1.8% |
| Diabetes Mellitus |
1.8% |
| Laryngeal Cancer |
1.8% |
| Multiple Sclerosis |
1.8% |
| Type 2 Diabetes Mellitus |
1.8% |
| Empyema |
1.2% |
| Enterococcus Test Positive |
1.2% |
|
| Renal Failure Acute |
11.8% |
| Toxic Epidermal Necrolysis |
8.8% |
| Vitamin K Deficiency |
8.8% |
| Acute Generalised Exanthematous Pustulosis |
5.9% |
| International Normalised Ratio Increased |
5.9% |
| Off Label Use |
5.9% |
| Pulmonary Eosinophilia |
5.9% |
| Pyrexia |
5.9% |
| Renal Failure |
5.9% |
| Renal Impairment |
5.9% |
| Agranulocytosis |
2.9% |
| Anaphylactic Reaction |
2.9% |
| Death |
2.9% |
| Drug Interaction |
2.9% |
| Erythema |
2.9% |
| Laboratory Test Abnormal |
2.9% |
| Leukocytoclastic Vasculitis |
2.9% |
| Leukopenia |
2.9% |
| Mastication Disorder |
2.9% |
| Myositis |
2.9% |
|
| Concomitant |
| Nephrotic Syndrome |
11.8% |
| Abdominal Distension |
9.6% |
| Psoriasis |
8.6% |
| Drug Use For Unknown Indication |
7.2% |
| Gastrointestinal Disorder |
7.2% |
| Hypertension |
7.2% |
| Pain |
5.9% |
| Hepatic Neoplasm Malignant |
4.8% |
| Prophylaxis |
4.5% |
| Diagnostic Procedure |
3.7% |
| Diabetes Mellitus |
3.5% |
| Skin Infection |
3.5% |
| Product Used For Unknown Indication |
3.2% |
| Rheumatoid Arthritis |
3.2% |
| Insomnia |
2.9% |
| Thrombosis Prophylaxis |
2.9% |
| Nausea |
2.7% |
| Prophylaxis Against Diarrhoea |
2.7% |
| Arthritis |
2.4% |
| Diarrhoea |
2.4% |
|
| Nephrotic Syndrome |
16.7% |
| Death |
9.3% |
| Vasculitis |
7.4% |
| Drug Ineffective |
5.6% |
| Drug Rash With Eosinophilia And Systemic Symptoms |
5.6% |
| Oedema Peripheral |
5.6% |
| Coagulation Factor Increased |
3.7% |
| Haemoglobin Decreased |
3.7% |
| Lipase Increased |
3.7% |
| Nuchal Rigidity |
3.7% |
| Pancreatitis |
3.7% |
| Psoriasis |
3.7% |
| Renal Failure Acute |
3.7% |
| Sepsis |
3.7% |
| Skin Lesion |
3.7% |
| Tachypnoea |
3.7% |
| Therapeutic Product Ineffective |
3.7% |
| Urinary Tract Infection |
3.7% |
| Ventricular Fibrillation |
3.7% |
| Abortion Spontaneous |
1.9% |
|
| Interacting |
| Atrial Fibrillation |
50.0% |
| Device Related Infection |
25.0% |
| Thrombophlebitis Superficial |
25.0% |
|
| Coagulation Time Prolonged |
50.0% |
| Mucocutaneous Candidiasis |
33.3% |
| Drug Interaction |
16.7% |
|
